Deepak Nitrite Ltd

- Rs. 14,000 crores investment announced for multiple projects including new phenol and acetone plant, downstream BPA, and a 200 KT aniline plant. - Ongoing projects worth around Rs. 2,000 crores in final stages of implementation, commissioning in current financial year. Includes MIBK, MIBC, nitric acid, enhanced nitration, hydrogenation, and specialty chemicals. - FY25 planned capex of about Rs. 1,200 crores; excludes polycarbonate compounding project. - Separate polycarbonate compounding pilot plant (30,000 tonnes/year) being set up, fungible and aimed at customer validation; large-scale compounding capex to follow separately after validation. - Technology tie-ups for large projects expected by year-end; engineering and project execution teams working in stages for smooth rollout. - Past Rs. 2,000 crore capex split roughly 60% upstream integration, 40% downstream (excluding Rs. 300-350 crores in land and infrastructure). - Focus on completing current Rs. 2,000 crore projects by Q4 FY25 and ramping up larger MOUs from FY26 onward.

- Early indicators of increased volume and improved customer sentiment observed in Q1 FY25. - Short-term guidance anticipates a meaningful recovery starting from the latter part of Q3 FY25. - Domestic market shows high industrial activity with healthy demand levels; volume growth noted (5% overall growth in Advanced Intermediates). - Anticipation of higher demand and stronger product realizations by year-end FY25. - Continued volume recovery expected in most products except a few agrochemicals still soft. - New product launches and expanded capacity (e.g., 18-20% increase in DASDA and OBA) support growth. - Export volumes face pricing pressure due to China destocking, but domestic volumes are growing. - FY24-25 marks the start of a transformative journey with key projects and R&D investments to bolster growth. - Company focusing on expanding in specialty chemicals and engineering application chemicals alongside commodity segments.

- Deepak Nitrite anticipates a meaningful recovery in earnings and operating profits starting from the latter part of Q3 FY25 despite ongoing pricing pressures and industry challenges. - The company projects double-digit growth supported by volume improvement, enhanced customer sentiment, and operational efficiencies. - EBITDA and EBIT margins are expected to improve as expansion and debottlenecking projects complete, including downstream phenol, BPA, and polycarbonate plants. - FY25 capex of Rs. 1,200-2,000 crores focuses on projects that will enhance capacities and integration, with larger projects slated for FY26 onwards. - Sustained demand in phenolics and improving domestic volumes in advanced intermediates support growth. - Efficiency initiatives and sustainability efforts underpin long-term margin expansion. - The company targets growth driven by expanding product portfolio and market penetration, with focus on specialty chemicals and building blocks. - Management remains optimistic about the medium-term earnings trajectory tied to capacity expansions and market conditions stabilizing.

The transcript on page 17 (and surrounding pages) does not provide explicit details regarding the current or expected order book or pending orders for Deepak Nitrite Limited. However, some relevant points can be inferred: - The company is executing multiple large projects including specialty chemicals, phenol, BPA, polycarbonate, and advanced intermediates with a capex of around Rs. 14,000 crores. - Rs. 2,000 crores worth of projects are expected to be completed by Q4 FY25, with focus shifting to larger MOUs post that. - The management highlighted strong demand and volume growth in various segments despite pricing pressure and supply chain challenges. - There is mention of cautious but improving customer sentiment and expected recovery from the latter part of Q3 FY25. - No explicit order book figures or pending orders data were disclosed during the call. Thus, while project execution and demand visibility are positive, no quantifiable order book or pending order value is specified.

- The company is funding current projects through a mix of debt and internal accruals. - A new project funding proposition is being worked out and will be shared at an appropriate time. - The company has a strong balance sheet with continuing cash generation of around Rs. 1,000 crores per annum. - There is no explicit mention of any immediate or planned equity fundraising in the transcript. - Focus is on executing ongoing capex projects largely funded internally or by debt. - Overall, any future fundraising plans, either debt or equity, are not detailed but will be communicated when decided.